Control da Regulación Xénica en Enfermidades
Regulación Xénica
![Foto de Control da Regulación Xénica en Enfermidades](/img/grupo.png)
![Foto de Ikerbasque, Fundación Vasca para la Ciencia](/img/noimage_org.png)
Ikerbasque, Fundación Vasca para la Ciencia
Bilbao, EspañaPublicacións en colaboración con investigadores/as de Ikerbasque, Fundación Vasca para la Ciencia (27)
2024
-
Neddylation orchestrates the complex transcriptional and posttranscriptional program that drives Schwann cell myelination
Science Advances, Vol. 10, Núm. 15
2023
-
Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression
Hepatology, Vol. 77, Núm. 5, pp. 1654-1669
-
Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting
Cell Metabolism, Vol. 35, Núm. 8, pp. 1373-1389.e8
2022
-
Application of adipose-derived mesenchymal stem cells in an in vivo model of peripheral nerve damage
Frontiers in Cellular Neuroscience, Vol. 16
-
HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer models
Advanced Drug Delivery Reviews, Vol. 181
-
Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis
Nature Communications, Vol. 13, Núm. 1
-
Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals
Hepatology, Vol. 75, Núm. 3, pp. 550-566
2021
-
Axo-glial interaction in the injured PNS
Developmental Neurobiology, Vol. 81, Núm. 5, pp. 490-506
-
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury
JHEP Reports, Vol. 3, Núm. 3
-
E2F1 and E2F2-mediated repression of CPT2 establishes a lipid-rich tumor-promoting environment
Cancer Research, Vol. 81, Núm. 11, pp. 2874-2887
-
O-GlcNAcylated p53 in the liver modulates hepatic glucose production
Nature Communications, Vol. 12, Núm. 1
2020
-
Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation
Nature Communications, Vol. 11, Núm. 1
-
Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly
Cell Metabolism, Vol. 31, Núm. 3, pp. 605-622.e10
2019
-
miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease
Molecular Metabolism, Vol. 29, pp. 40-54
2018
-
Analyzing autophagic flux in nerve cultures
Methods in Molecular Biology (Humana Press Inc.), pp. 193-206
-
Isolation and purification of primary rodent schwann cells
Methods in Molecular Biology (Humana Press Inc.), pp. 81-93
-
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
Cell Death and Disease, Vol. 9, Núm. 10
-
Preface
Methods in Molecular Biology
2017
-
Role of aramchol in steatohepatitis and fibrosis in mice
Hepatology Communications, Vol. 1, Núm. 9, pp. 911-927
-
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury
Nature Communications, Vol. 8, Núm. 1